Year archive

Active Biotech — 2009 filings

All 55 regulatory filings released by Active Biotech (ACTI) in 2009, sourced directly from the official regulator.

55 Filings

2009 Period

2009 filings (55)

Filing	Released	Lang
Primärt mål uppnått i klinisk fas II-prövning för Active Biotechs prostatacancerprojekt TASQ Earnings Release FY 2009	2009-12-14	Swedish
Primary endpoint reached in Active Biotech's TASQ Phase II clinical trial in prostate cancer patients Regulatory Filings	2009-12-14	English
Interim / Quarterly Report 2009 Interim / Quarterly Report 9M 2009	2009-11-05	Swedish
Interim / Quarterly Report 2009 Interim / Quarterly Report 9M 2009	2009-11-05	English
Active Biotechs valberedning utsedd AGM Information	2009-11-05	Swedish
Active Biotech's election committee appointed AGM Information	2009-11-05	English
Det brittiska läkemedelsverket ger klartecken för fortsatt klinisk utveckling av RhuDex Regulatory Filings	2009-10-05	Swedish
RhuDex Clinical Development to Continue Following Feedback from Regulatory Authorities Regulatory Filings	2009-10-05	English
Active Biotechs prostatacancerprojekt TASQ presenteras i British Journal of Cancer Regulatory Filings	2009-09-25	Swedish
Active Biotech's Prostate Cancer Project TASQ Featured in British Journal of Cancer Regulatory Filings	2009-09-25	English
Active Biotech presenterar på UBS Global Life Sciences Conference Investor Presentation	2009-09-17	Swedish
Active Biotech to Present at the UBS Global Life Sciences Conference Investor Presentation	2009-09-17	English
LAQUINIMODS IMMUNMODULERANDE MEKANISM HAR BÅDE NERVSKYDDANDE OCH ANTI-INFLAMMATORISKA EGENSKAPER Regulatory Filings	2009-09-11	Swedish
LAQUINIMOD IMMUNOMODULATORY ACTION CONFERS BOTH NEUROPROTECTIVE AND ANTI-INFLAMMATORY PROPERTIES Investor Presentation	2009-09-11	English
Laquinimod presenteras på ECTRIMS Regulatory Filings	2009-09-08	Swedish
Laquinimod presentations at ECTRIMS Regulatory Filings	2009-09-08	English
Active Biotech presenterar på Rodman & Renshaw 11th Annual Healthcare Conference Investor Presentation	2009-09-04	Swedish
Active Biotech to Present at the Rodman & Renshaw 11th Annual Healthcare Conference Investor Presentation	2009-09-04	English
Ny information kring RhuDex(TM) Report Publication Announcement	2009-08-07	Swedish
Ny information kring RhuDex(TM) Regulatory Filings	2009-08-07	English
Interim / Quarterly Report 2009 Interim / Quarterly Report H2 2009	2009-08-06	Swedish
Interim / Quarterly Report 2009 Interim / Quarterly Report H2 2009	2009-08-06	English
Active Biotechs cancerprojekt ANYARA presenteras i Journal of Clinical Regulatory Filings	2009-07-28	Swedish
Active Biotech's Cancer Project ANYARA Featured in Journal of Clinical Regulatory Filings	2009-07-28	English
Antal aktier och röster i Active Biotech Declaration of Voting Results & Voting Rights Announcements	2009-06-30	Swedish
Number of shares and votes in Active Biotech Declaration of Voting Results & Voting Rights Announcements	2009-06-30	English
BRAVO-studien för laquinimod fullrekryterad Regulatory Filings	2009-06-25	Swedish
Teva Completes Enrollment in Second Oral Laquinimod Phase III MS Clinical Trial Investor Presentation	2009-06-25	English
Active Biotechs nyemission kraftigt övertecknad Capital/Financing Update	2009-06-15	Swedish
Active Biotech's rights issue substantially oversubscribed Capital/Financing Update	2009-06-15	English
Active Biotech presenterar data rörande SLE-projektet 57-57 på EULAR Regulatory Filings	2009-06-11	Swedish
Active Biotech Presents Data regarding the 57-57 SLE Project at EULAR Regulatory Filings	2009-06-11	English
Patientrekryteringen till Active Biotechs kliniska fas II-studie för TASQ avslutad Regulatory Filings	2009-06-08	Swedish
Active Biotech Completes Patient Enrollment to TASQ Clinical Phase II study Regulatory Filings	2009-06-08	English
Patientrekryteringen till Active Biotechs kliniska fas III-studie för ANYARA avslutad Regulatory Filings	2009-06-01	Swedish
Active Biotech Completes Patient Enrollment to ANYARA Phase III Clinical Trial Regulatory Filings	2009-06-01	English
Offentliggörande av prospekt avseende nyemission i Active Biotech AB (publ) Report Publication Announcement	2009-05-18	Swedish
Announcement of prospectus regarding rights issue in Active Biotech AB (publ) Report Publication Announcement	2009-05-18	English
Årsstämma i Active Biotech AB AGM Information	2009-05-08	Swedish
Annual General Meeting of Active Biotech AB AGM Information	2009-05-08	English
NYA RÖN KRING VERKNINGSMEKANISMEN FÖR LAQUINIMOD, EN NY ORAL BEHANDLING AV MULTIPEL SKLEROS Regulatory Filings	2009-04-28	Swedish
NEW DATA ILLUSTRATE NOVEL MECHANISM OF ACTION OF LAQUINIMOD, AN ORAL COMPOUND FOR THE TREATMENT OF MULTIPLE SCLEROSIS Regulatory Filings	2009-04-28	English
Interim / Quarterly Report 2009 Interim / Quarterly Report Q1 2009	2009-04-23	Swedish
Interim / Quarterly Report 2009 Interim / Quarterly Report Q1 2009	2009-04-23	English
Major Shareholding Notification 2009 Major Shareholding Notification	2009-04-16	English
Annual Report 2008 Annual Report FY 2008	2009-04-07	English
Annual Report 2008 Annual Report FY 2008	2009-04-06	Swedish
Report Publication Announcement 2009 Report Publication Announcement	2009-04-06	Swedish
Report Publication Announcement 2009 Report Publication Announcement	2009-04-06	English
Earnings Release 2009 Earnings Release FY 2009	2009-02-12	English
Regulatory Filings 2009 Regulatory Filings	2009-02-12	Swedish
Interim / Quarterly Report 2008 Interim / Quarterly Report FY 2008	2009-02-12	Swedish
Annual Report 2008 Annual Report FY 2008	2009-02-12	English
Board/Management Information 2009 Board/Management Information	2009-01-26	Swedish
Board/Management Information 2009 Board/Management Information	2009-01-26	English

Filings by year

2026 11 filings
2025 41 filings
2024 45 filings
2023 32 filings
2022 42 filings
2021 48 filings
2020 41 filings
2019 45 filings
2018 38 filings
2017 33 filings
2016 40 filings
2015 40 filings
2014 49 filings
2013 58 filings
2012 58 filings
2011 56 filings
2010 62 filings
2009 55 filings
2008 28 filings
2007 8 filings